يعرض 1 - 20 نتائج من 22 نتيجة بحث عن '(( significant decrease decrease ) OR ( significant ((marked decrease) OR (work increased)) ))~', وقت الاستعلام: 0.50s تنقيح النتائج
  1. 1

    Basic characteristics of the afforested land. حسب Yao Zhong (280645)

    منشور في 2025
    "…Although afforestation increased POC contents in both soil layers (9.70 and 7.82 g·kg ⁻ ¹, respectively), it markedly reduced the more stable MAOC contents (from 9.53 and 9.62 g·kg ⁻ ¹ to 7.53 and 6.08 g·kg ⁻ ¹ in the 0–0.15 m and 0.15–0.30 m layers, respectively) and MAOM mass fractions (from 77.46% to 68.16% and from 78.69% to 71.61%). …"
  2. 2
  3. 3

    Table 1_The impact of diagnosis-related group-based medical insurance payment model on the prognosis and nursing care of patients undergoing composite trabeculectomy: a retrospecti... حسب Yu Wang (12152)

    منشور في 2025
    "…Furthermore, the reform was associated with a marked decrease in hospitalization expenses and nursing costs. …"
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    DataSheet1_RETRACTED: Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn.DOCX حسب Kislay Roy (3466256)

    منشور في 2025
    "…Treatments with TSA and SurR9-C84A for 40 min led to improvement in the conjunctival and corneal tissue integrity, marked by an increase in clathrin, and claudin expressions. …"
  14. 14
  15. 15

    Image 4_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.tiff حسب Øystein Fluge (200378)

    منشور في 2025
    "…Four patients had no significant clinical changes. Six patients experienced marked improvement. …"
  16. 16
  17. 17

    Data Sheet 1_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.pdf حسب Øystein Fluge (200378)

    منشور في 2025
    "…Four patients had no significant clinical changes. Six patients experienced marked improvement. …"
  18. 18

    Image 2_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.tiff حسب Øystein Fluge (200378)

    منشور في 2025
    "…Four patients had no significant clinical changes. Six patients experienced marked improvement. …"
  19. 19

    Image 3_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.tiff حسب Øystein Fluge (200378)

    منشور في 2025
    "…Four patients had no significant clinical changes. Six patients experienced marked improvement. …"
  20. 20

    Table 1_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.xlsx حسب Øystein Fluge (200378)

    منشور في 2025
    "…Four patients had no significant clinical changes. Six patients experienced marked improvement. …"